JVMCX
Price
$26.03
Change
+$0.25 (+0.97%)
Updated
Jun 6 closing price
Net Assets
21.45B
LMCSX
Price
$32.71
Change
+$0.26 (+0.80%)
Updated
Jun 6 closing price
Net Assets
1.08B
Interact to see
Advertisement

JVMCX vs LMCSX

Header iconJVMCX vs LMCSX Comparison
Open Charts JVMCX vs LMCSXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$26.03
Change+$0.25 (+0.97%)
VolumeN/A
Net Assets21.45B
Lord Abbett Mid Cap Stock R4
Price$32.71
Change+$0.26 (+0.80%)
VolumeN/A
Net Assets1.08B
JVMCX vs LMCSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMCX vs. LMCSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and LMCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. LMCSX (1.08B). LMCSX pays higher dividends than JVMCX: LMCSX (0.58) vs JVMCX (0.00). JVMCX was incepted earlier than LMCSX: JVMCX (14 years) vs LMCSX (10 years). JVMCX (1.88) is less costly to investors than LMCSX (1.03). LMCSX is a more actively managed with annual turnover of: 53.00 vs. JVMCX (47.00). LMCSX has a lower initial minimum investment than JVMCX: LMCSX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -4.66 vs. LMCSX (-5.08). JVMCX return over 5 years is better than : 33.39 vs. LMCSX (29.59).
JVMCXLMCSXJVMCX / LMCSX
Total Expense Ratio1.871.03182%
Annual Report Gross Expense Ratio1.881.03183%
Fund Existence14 years10 years-
Gain YTD1.897-3.537-54%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets21.5B1.08B2,000%
Annual Yield % from dividends0.000.58-
Returns for 1 year-4.66-5.0892%
Returns for 3 years1.473.1846%
Returns for 5 years33.3929.59113%
Returns for 10 years25.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FTXL87.420.37
+0.43%
First Trust Nasdaq Semiconductor ETF
VUSB49.61-0.01
-0.02%
Vanguard Ultra-Short Bond ETF
XPP24.45-0.05
-0.22%
ProShares Ultra FTSE China 50
PCRB48.16-0.25
-0.52%
Putnam ESG Core Bond ETF